Endocrinology Research and Practice
Original Article

Treatment of Amiodarone-Induced Thyrotoxicosis with Plasmapheresis and Thyroidectomy

1.

Department of Endocrinology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey

2.

Department of Surgery, Cumhuriyet University, Medical School, Sivas, Turkey

3.

Department of Endocrinology, Cumhuriyet University, Medical School, Sivas, turkey

4.

Department of Surgery, Cumhuriyet University, Medical School, Sivas, turkey

Endocrinol Res Pract 2000; 4: 67-69
Read: 1359 Downloads: 488 Published: 21 March 2022
ABSTRACT
Amiodarone is an antiarhythmic drug which may produce secondary effects on the thyroid function. We report a case of severe amiodarone-induced thyrotoxicosis in a 56-year-old patient. Because of dramatic clinical manifestations, plasmapheresis was performed as a first step in management of thyrotoxicosis and an improvemen t of clinical status was observed. Pharmacological therapy with thionamide, dexamethasone, betablocker and lithium carbonate was started. Clinical status worsened progressively and the decision to operate was made after 9 weeks of inefficient pharmacological therapy. Before surgery, the patient was submitted to plasmapheresis daily and she became euthyroid after the 5th plasmapheresis. Subsequently, total thyroidectomy was performed which resulted in an absolute cure of thyrotoxicosis without complications. We suggest that a combination of plasmapheresis and thyroidectomy warrants consideration as definitive treatment for resistant amiodarone-induced thyro - toxicosis.
 
Files
EISSN 2822-6135